On March 14th, according to a report from the Daily Mail, Associate Professor Becky Freeman from the University of Sydney in Australia published an article in the journal Public Health Research and Practice stating that only pharmacies should be allowed to sell imported e-cigarettes, and these e-cigarettes should only be available for prescription needs related to quitting smoking. Freeman also stated that the only way for Australia to rid itself of nicotine e-cigarettes is to ban all commercial sales of e-cigarettes.
According to 2FIRSTS, as of October 2021, Australia will prohibit the import of nicotine-containing electronic cigarettes without a prescription. However, Professor Freeman states that local retailers, manufacturers, and importers in Australia still label nicotine-containing electronic cigarettes as nicotine-free in order to secretly bring them into the Australian market.
Professor Freeman stated that legal importation of nicotine-free e-cigarettes is a loophole for importers, while a complete ban on their importation would protect young people. However, it may be acceptable to allow the use of e-cigarettes for smoking cessation purposes, but this would require a prescription from a doctor.
She added that the decrease in the number of nicotine e-cigarettes entering Australia will make enforcing existing laws easier.
According to a survey launched by the Australian Department of Health in 2022, one-third of adolescents aged 14 to 17 have tried vaping.
The Queensland Parliament in Australia is set to introduce new legislation on Tuesday that will seek to crack down on illegal nicotine products, establish more smoke-free areas, and restrict the sale of tobacco in licensed venues.
Related reading;
Queensland, Australia initiates an investigation into electronic cigarettes with potential changes to related legislation.
Reference:
Obtaining and Usage of E-Cigarette Products Among Adolescents Aged 14-17: A Cross-Sectional Study.
There are growing demands to prohibit the sale of all vaping products in Australia, except when prescribed by a doctor to assist patients in quitting smoking.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
